Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Darexaban vs mechanical prophylaxis in major abdominal surgery
NCT00942435Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Jun 2009
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of darexaban in venous thromboembolism (VTE) (2 arms), sponsored by Astellas Pharma. Primary endpoint: Composite assessment of venous thromboembolism events and all causes of death at Day 12. Started Jun 2009; status: completed.
02
Drugs
darexaban
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT00942435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00942435.